DrTalks Expert

Gordan Lauc, PhD

View profile as guest

Biography

Gordan Lauc is the Professor of Biochemistry and Molecular Biology at the University of Zagreb, Director of the National Centre of Scientific Excellence in Personalised Healthcare, honorary professor at the University of Edinburgh and the Kings College London and member of the Johns Hopkins Society of Scholars. In 2017 he initiated the launch of the Human Glycome project and is one of its two co-directors. His research team is pioneering high throughput glycomic analysis and the application of glycan biomarkers in the field of precision medicine. By combining glycomic data with extensive genetic, epigenetic, biochemical and physiological data in a systems biology approach they are trying to understand the role of glycans in normal physiology and disease. Professor Lauc co-authored over 200 research articles that are cited over 5,000 times. In 2007 he founded Genos, a biotech company that is currently global leader in high-throughput glycomics. Research in Genos led to the development of the GlycanAge test of biological age.

Content

Glycans As Biomarkers On Ageing And Disease

Premium

Glycans As Biomarkers On Ageing And Disease

March 3, 2023

Video

Premium

Glycans Are Modifiable Biomarkers And Functional Effectors Of Ageing And Age-Related Diseases

Premium

Glycans Are Modifiable Biomarkers And Functional Effectors Of Ageing And Age-Related Diseases

November 15, 2022

Video

Premium

Premium

The Newest Biomarker Of Aging: Breaking Down The GlycanAge Test In Detail

October 20, 2021

Video

Premium

12

Professions

Education

Certifications

Gordan Lauc, PhD

Gordan Lauc is the Professor of Biochemistry and Molecular Biology at the University of Zagreb, Director of the National Centre of Scientific Excellence in Personalised Healthcare, honorary professor at the University of Edinburgh and the Kings College London and member of the Johns Hopkins Society of Scholars. In 2017 he initiated the launch of the Human Glycome project and is one of its two co-directors. His research team is pioneering high throughput glycomic analysis and the application of glycan biomarkers in the field of precision medicine. By combining glycomic data with extensive genetic, epigenetic, biochemical and physiological data in a systems biology approach they are trying to understand the role of glycans in normal physiology and disease. Professor Lauc co-authored over 200 research articles that are cited over 5,000 times. In 2007 he founded Genos, a biotech company that is currently global leader in high-throughput glycomics. Research in Genos led to the development of the GlycanAge test of biological age.

Contents Provided